News & Updates

Check here regularly for news about medical imaging and updates from MITA.

  • MITA News

    The Association for the Advancement of Medical Instrumentation and the Food and Drug Administration are co-convening their 7th summit, this year on “risk management.” This event will bring together leaders and risk management experts in the medical device industry and healthcare delivery, along with regulators, educators, and clinicians. MITA will be a Supporting Organization of this summit.

  • MITA NewsMITA Statement

    The National Electrical Manufacturers Association (NEMA) welcomed the announcement by U.S. Trade Representative Michael Froman that agreement had been reached among a leading group of countries to expand the scope of the World Trade Organization’s Information Technology Agreement (WTO ITA). According to the announcement, a product list including magnetic resonance imaging (MRI), ultrasound, and computed tomography (CT) units as well as other specific products of interest to NEMA manufacturers has been provisionally agreed by participating governments.

  • MITA News

    The Medical Imaging and Technology Alliance (MITA) has commended US House Rep Seth Moulton, D-Mass, for supporting repeal of the medical device tax.

  • MITA News

    The device tax, a tax that even the Congressional Research Service says is “challenging to justify,” since excise taxes are generally used to discourage undesirable activities such as smoking, just isn’t a lynch pin to the fate of the law. No matter what happens to Obamacare, one fact remains: The medical device tax stymies innovation, creating unnecessary hurdles for both established manufacturers and start-ups, which rely equally on pushing boundaries to realize what was once only imagined.

  • MITA News

    The standards were developed by the Medical Imaging & Technology Alliance (MITA), which is a division of the Arlington, VA-based National Electrical Manufacturers Association. The CT scan standards, which are designated as XR-29 by MITA and Congress, have “four key features,” according to Dominic Siewko, clinical marketing director for Andover, MA-based Philips Healthcare, a MITA member.

  • Industry News

    For women with dense tissue, mammograms can be less accurate so new tests offer better detection but often more false alarms. As of now, only about 100 hospitals offer the newest molecular breast imaging technology, which is made by GE Healthcare and Gamma Medica Inc. But with costs as low as $300, it could grow rapidly, particularly if additional studies yield similar results.

  • MITA News

    We take issue with your argument that medical technology companies, like insurers and pharmaceutical companies, profit from expanded health insurance coverage under the Affordable Care Act.

  • MITA News

    Gail Rodriguez, executive director of the Medical Imaging & Technology Alliance (MITA), suggested that, apart from Hughes’ study, there’s ample anecdotal evidence pointing to physicians’ support of advanced imaging for a very simple reason: steady technological improvement. “When I started in imaging 20 some-odd years ago, the sensitivity and specificity were acceptable; they were OK,” said Rodriguez.

  • MITA News

    When asked if advanced imaging could replace invasive procedures, 69 percent of physicians with less than 20 years of practice agreed. Among physicians with 20 or more years of experience 84 percent agreed. Christine Hughes suggested that recalling an era before advanced imaging could make the more experienced PCPs stronger endorsers of the newer technology.

  • Industry News

    Many primary care physicians (PCPs) believe that advanced medical imaging adds considerable value to patient care, according to a study published in the Journal of the American College of Radiology.


    Albin Sikora
    (202) 585-2727

  • Imaging Forward

    In just 20 years, medical imaging has dramatically improved health outcomes and lowered costs. Imagine what the future holds. Learn More

  • The State of Medical Imaging

    New MITA Infographic highlights the current threats to medical imaging, as well as patient-centered policy proposals. Learn More

  • Navidea

    Why I Joined MITA – Navidea Biopharmaceuticals

    Hear from Thomas Tulip, Executive Vice President and Chief Business Officer of Navidea Biopharmaceuticals, on why his organization joined MITA.

    Learn More